MMP-2 and 9 in Chronic Kidney Disease

Int J Mol Sci. 2017 Apr 8;18(4):776. doi: 10.3390/ijms18040776.

Abstract

Gelatinases are members of the matrix metalloproteinase (MMPs) family; they play an important role in the degradation of the extracellular matrix (ECM). This effect is also crucial in the development and progression of chronic kidney disease (CKD). Its expression, as well as its activity regulation are closely related to the cell signaling pathways, hypoxia and cell membrane structural change. Gelatinases also can affect the development and progression of CKD through the various interactions with tumor necrosis factors (TNFs), monocyte chemoattractant proteins (MCPs), growth factors (GFs), oxidative stress (OS), and so on. Currently, their non-proteolytic function is a hot topic of research, which may also be associated with the progression of CKD. Therefore, with the in-depth understanding about the function of gelatinases, we can have a more specific and accurate understanding of their role in the human body.

Keywords: chronic kidney disease; gelatinases; matrix metalloproteinase; non-proteolytic function.

Publication types

  • Review

MeSH terms

  • Disease Progression
  • Extracellular Matrix / metabolism*
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Matrix Metalloproteinase 2 / metabolism*
  • Matrix Metalloproteinase 9 / metabolism*
  • Monocyte Chemoattractant Proteins / metabolism
  • Protein Binding
  • Renal Insufficiency, Chronic / enzymology*
  • Renal Insufficiency, Chronic / metabolism
  • Renal Insufficiency, Chronic / pathology
  • Tumor Necrosis Factors / metabolism

Substances

  • Intercellular Signaling Peptides and Proteins
  • Monocyte Chemoattractant Proteins
  • Tumor Necrosis Factors
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9